LYPHOMED  LMED SELLS CONVERTIBLE DEBENTURES NEW YORK MARCH 13 LYPHOMED INC IS RAISING 70 MLN DLRS THROUGH AN OFFERING OF CONVERTIBLE SUBORDINATRED DEBENTURES DUE 2012 WITH A 5 1 2 PCT COUPON AND PAR PRICING SAID LEAD MANAGER ALEX BROWN AND SONS INC THE DEBENTURES ARE CONVERTIBLE INTO THE COMPANY'S COMMON STOCK AT 3625 DLRS PER SHARE REPRESENTING A PREMIUM OF 2775 PCT OVER THE STOCK PRICE WHEN TERMS ON THE DEBT WERE SET NON CALLABLE FOR TWO YEARS THE ISSUE IS RATED BB BY STANDARD AND POOR'S CORP MONTGOMERY SECURITIES CO MANAGED THE DEAL   